Preoperative chemotherapy for women with operable breast cancer - Wikidata - awgldk - TriplyDB

Preoperative chemotherapy for women with operable breast cancer

Preoperative chemotherapy for women with operable breast cancer

http://www.wikidata.org/entity/Q24245281

about

Dual HER2 blockade in the neoadjuvant and adjuvant treatment of HER2-positive breast cancer AACR Cancer Progress Report 2014 Optimal management of breast cancer in the elderly patient: current perspectives Oncoplastic breast surgery: current strategies Efficacy of carboplatin-based preoperative chemotherapy for triple-negative breast cancer. A meta-analysis of randomized controlled trials Pathological complete response as a surrogate for relapse-free survival in patients with triple negative breast cancer after neoadjuvant chemotherapy Meta-analysis on the association between pathologic complete response and triple-negative breast cancer after neoadjuvant chemotherapy Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer.Impact of neoadjuvant chemotherapy on immediate breast reconstruction: a meta-analysis.Additional value of 18F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer Magnetic resonance imaging shrinkage patterns following neoadjuvant chemotherapy for breast carcinomas with an emphasis on the radiopathological correlations Therapeutic options for HER-2 positive breast cancer: Perspectives and future directions Topo2α protein expression predicts response to anthracycline combination neo-adjuvant chemotherapy in locally advanced primary breast cancer.An elevated peripheral blood lymphocyte-to-monocyte ratio predicts favorable response and prognosis in locally advanced breast cancer following neoadjuvant chemotherapy.Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer.Tumor Infiltrating Lymphocytes - The Next Step in Assessing Outcome and Response to Treatment in Patients with Breast Cancer Neoadjuvant chemotherapy and short-term morbidity in patients undergoing mastectomy with and without breast reconstruction.Can ki-67 play a role in prediction of breast cancer patients' response to neoadjuvant chemotherapy?Review of breast conservation therapy: then and now Safety and feasibility of adjuvant chemotherapy with S-1 in Japanese breast cancer patients after primary systemic chemotherapy: a feasibility study.Women with large (≥3 cm) and locally advanced breast cancers (T3, 4, N1, 2, M0) receiving neoadjuvant chemotherapy (NAC: cyclophosphamide, doxorubicin, docetaxel): addition of capecitabine improves 4-year disease-free survival.Texture analysis on MR images helps predicting non-response to NAC in breast cancer Higher locoregional recurrence rate for triple-negative breast cancer following neoadjuvant chemotherapy, surgery and radiotherapy Platelet-Lymphocyte Ratio as a Useful Predictor of the Therapeutic Effect of Neoadjuvant Chemotherapy in Breast Cancer Clinical implications of molecular heterogeneity in triple negative breast cancer.Clinical verification of sensitivity to preoperative chemotherapy in cases of androgen receptor-expressing positive breast cancer.Predictive Value of Neutrophil/Lymphocyte Ratio for Efficacy of Preoperative Chemotherapy in Triple-Negative Breast Cancer.Neoadjuvant dose-dense gemcitabine plus docetaxel and vinorelbine plus epirubicin for operable breast cancer: improved prognosis in triple-negative tumors.Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer.Population and target considerations for triple-negative breast cancer clinical trials.Targets for Neoadjuvant Therapy - The Preferences of Patients with Early Breast Cancer.A Decision Aid for Women Considering Neoadjuvant Systemic Therapy for Operable Invasive Breast Cancer: Development and Protocol of a Phase II Evaluation Study (ANZ1301 DOMINO).Neoadjuvant chemotherapy and targeted therapy in breast cancer: past, present, and future.The Feasibility of Using Metacognitive Strategy Training to Improve Cognitive Performance and Neural Connectivity in Women with Chemotherapy-Induced Cognitive Impairment.Association of PTP1B with Outcomes of Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy.Treatment response assessment of breast masses on dynamic contrast-enhanced magnetic resonance scans using fuzzy c-means clustering and level set segmentation The Role of Carboplatin in the Neoadjuvant Chemotherapy Treatment of Triple Negative Breast Cancer Neoadjuvant Chemotherapy in Breast Cancer Patients Induces miR-34a and miR-122 Expression.Neoadjuvant chemotherapy in breast cancers.Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging

P2860

Q26785612-CA1EF8C6-49B6-4B04-93A5-CC49A3E94790 Q27346723-A71F2BA0-D631-49BE-9397-EDD2D14A45C4 Q27690879-F7D60867-BF5E-414A-943A-5A5DC34E0B1A Q28082147-38312D39-DED9-441F-85F5-E42B96935F03 Q33438050-81BA1A1F-8935-417A-83A4-F70FE9B7DE0C Q33566963-FA476F9F-7DBA-4D25-8D69-9D0872BCD54A Q33573055-2E5205B6-C033-4D90-AABB-01BC6783C4B6 Q33668173-5F7BF110-84CB-4707-9940-01173161F496 Q33690155-E1E89E69-6553-4EFC-918F-179CA8B58F7B Q33730822-BCBE544D-4808-46BA-8DED-EA784C60CAAE Q33933029-954D7FB6-64A9-4CC0-8253-8B22E5CFD514 Q34023704-CBB2090F-B106-468A-9042-9A58FEDDDFD3 Q34433737-9FA6A4CE-5D1B-4CDD-8F20-C3C80525EF4A Q34457064-56143C71-A335-447C-8CDC-1F130BC41404 Q34984314-F4F6C0F3-1E2C-4FAF-88E8-936D212017F0 Q35149726-4AF33D0E-B701-4C08-8B23-4C04C31AE1E0 Q35155591-F023BB30-AAAB-46D8-B966-C9EB213118F8 Q35160045-DD05226C-4FC7-4826-8DFD-17C78F6478EA Q35433289-B5EE2962-7581-4F59-89E7-A0028822C6C8 Q35530220-01D23B4A-D8CB-431F-984F-FE1B72312387 Q35599471-E06B22C6-4B68-43A0-A974-37A789E7B9B6 Q35737991-D2DC811D-28A7-479C-9F34-E8914684DA55 Q35901372-867C7E94-F403-4750-ABCB-DCD9F839DAF2 Q36089813-8833F907-97AE-4657-8A1B-20B2EB480DFA Q36271396-778870DA-4EFC-4071-99A7-9D8B58E7A9BD Q36473017-7146C21A-F065-4AFD-B3B5-3F0DEEABC58E Q36637292-37EABE6E-4C66-4107-92A5-B830AC217DBB Q36649503-DEA88F14-35F5-405E-949D-5B2931AA539F Q36914142-1DF9DE31-664A-49AB-AD80-3211D256925F Q36914317-0F6D3F10-C35D-44D8-BF3B-08457BA1FBD9 Q36917634-AC196920-22E8-4B85-8C6B-C48ECD3386CA Q36968921-71CA7083-0529-47E8-B68D-DF518DCB374D Q37145188-231DAE40-67DF-4E20-AF06-9220EBD9015D Q37242525-A606E47A-DAF8-42C8-A875-703F7167FAB1 Q37397626-AA083ECE-CA6B-4B35-92A6-FC227479180B Q37412241-117FD97E-1B73-4C3E-86C7-4AE779231728 Q37720246-34EA3140-6F0E-4EA9-ACEA-DE37CD279F47 Q38970049-D41B9ECF-0C0B-4AB5-8CE8-3F7E1514370D Q39019234-5FF4E7B1-9B9B-4C26-83AB-56D28C167294 Q41276299-D210A19D-F288-4C1C-B91F-B1570FEF7498

P2860

Preoperative chemotherapy for women with operable breast cancer

http://www.wikidata.org/entity/Q24245281

description

2007 nî lūn-bûn

@nan

2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Preoperative chemotherapy for women with operable breast cancer

@ast

Preoperative chemotherapy for women with operable breast cancer

@en

Preoperative chemotherapy for women with operable breast cancer

@en-gb

Preoperative chemotherapy for women with operable breast cancer

@nl

type

label

Preoperative chemotherapy for women with operable breast cancer

@ast

Preoperative chemotherapy for women with operable breast cancer

@en

Preoperative chemotherapy for women with operable breast cancer

@en-gb

Preoperative chemotherapy for women with operable breast cancer

@nl

prefLabel

Preoperative chemotherapy for women with operable breast cancer

@ast

Preoperative chemotherapy for women with operable breast cancer

@en

Preoperative chemotherapy for women with operable breast cancer

@en-gb

Preoperative chemotherapy for women with operable breast cancer

@nl

P1433

Q24245281-0CEB970A-FC66-4130-8A52-419D447BF3A7

P1476

Q24245281-D426D67D-E470-4D81-BCE6-634D2F2C3C47

P2093

Q24245281-178B5DA6-3623-4859-A10A-CAC6315E112A

Q24245281-2CCA57B9-6C68-4784-8517-613204396226

Q24245281-671543EF-7135-45FE-8654-C336E5D79E75

P2860

Q24245281-056FE333-605B-4591-8B83-F684C9290479

Q24245281-062FA70C-C782-41B7-9A87-90C7DC28AA4A

Q24245281-08BF16A9-6D23-472C-9D59-B3BBF7446A60

Q24245281-1303147F-09FD-4134-B71C-1FAB7B316BC9

Q24245281-15C7AE3C-C33A-40E3-8FE6-68DEC7C06F28

Q24245281-1C18A55C-A8DD-4477-8AF5-63AA466875F0

Q24245281-21E36A50-58F9-4BF8-ABE3-3E4730913591

Q24245281-32F6C3D8-9A51-40FE-BEC9-23D91336D6D8

Q24245281-3AD20D59-DC18-4B99-A3A4-F33472F2BEDA

Q24245281-4AAAB851-E0F2-404B-A0A4-587E601F358A

P31

Q24245281-1307f61b-ce1e-4cf9-93b0-20c81cd776f6

Q24245281-6C00D608-708A-4592-960C-9002B2064492

P3181

Q24245281-6004BA33-5DCE-439F-B965-245D92197150

P356

Q24245281-9C9F11EC-2D10-4B8E-9701-6FAFA9D261C0

P577

Q24245281-C6BE4AE3-B712-4219-9A92-AF3B8F71F027

P698

Q24245281-10A15E8D-24CE-4FB5-9265-21FF256D1517

P921

Q24245281-69F0F0F3-E6A3-4375-BE75-956B660083F5

P3181

P356

14651858.CD005002.PUB2

P1433

Cochrane Database of Systematic Reviews

P1476

Preoperative chemotherapy for women with operable breast cancer

@en

P2093

Cornelis CJH van de Velde

http://www.w3.org/2001/XMLSchema#string

Jos H van der Hage

http://www.w3.org/2001/XMLSchema#string

Sven JSD Mieog

http://www.w3.org/2001/XMLSchema#string

P2860

Bias in meta-analysis detected by a simple, graphical test

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

Quantifying heterogeneity in a meta-analysis

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more.

Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis.

Primary systemic therapy in operable breast cancer.

Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.

P31

scholarly article

P3181

1475176

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/14651858.CD005002.PUB2

http://www.w3.org/2001/XMLSchema#string

P577

2007-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17443564

http://www.w3.org/2001/XMLSchema#string

P921